JNJNYSEPharmaceutical PreparationsFiscal year ends January 3

JOHNSON & JOHNSON

Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026

$253.79−1.77 (-0.69%)

Close on Oct 19, 2026

Community

Notes and questions about Johnson & Johnson from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Johnson & Johnson's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jun 13, 2001
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is JNJ.

Revenue growth8.1% · median 8.1%

Gross margin67.9% · median 73.0%

Net margin21.5% · median 9.8%

Advertisement
300 × 250